Our Scientific Achievements
Genea research has not only delivered huge advances in the past – such as when we virtually doubled IVF success rates in the mid-nineties – it delivers advances ongoingly. And all of the advances are focused on giving you, the Genea patient, a better journey and outcome today.
Genea was the first clinic in Australia to introduce routine Day 5 embryo transfers. Growing the embryos a little longer before transferring them to the mother lets us determine which embryos have the highest development potential and increases success rates. Day 3 to day 5 is a critical time because this is when an embryo switches genetic control from the mother’s genome to shared control between mother and father. This is a potential block point and transferring embryos beyond it is far more successful. We have given our patients world-leading success rates with this advancement for years, and other Australian clinics have only recently followed our lead.
Single embryo transfer
We were also the first clinic in Australia to introduce routine single embryo transfer. While many clinics transfer more than one embryo to try to improve their chances of success, our technology allows us to achieve higher success rates while transferring a single, carefully selected embryo.
The holy grail
To give you some idea of just how far ahead Genea is in assisted conception technology, consider this. An Australian IVF clinic recently stated that “the holy grail” for IVF technology right now would be the ability to test every one of the 23 chromosome pairs in the embryo before implantation. At Genea we have been doing just that since November 2010. Quite simply, if you want to ensure that you benefit from the very latest assisted conception research and technology you could do no better than come to Genea.